SS

Sameer Soni

Active Director Director DIN 09735573
DIN 09735573 First appointment Sep 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Sameer Soni

Data last updated:

Sameer Soni is a Director at Swarnkar Ayurveda Private Limited (since 2022). The company operates in Chemicals. Swarnkar Ayurveda Private Limited reported revenue of ₹2.7 Lakh (FY 2024).

DIN 09735573
Primary Designation Director
Industry Chemicals
First Appointment 13 Sep 2022
Oldest Company Age 4 yrs
Largest company Swarnkar Ayurveda Private Limited · ₹2.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Swarnkar Ayurveda Private Limited U24299MP2022PTC062687
Director13 Sep 20222022₹2.7 Lakh (FY 2024)Active

Board colleagues of Sameer Soni

Directorship timeline

Open interactive timeline →
Swarnkar Ayurveda Private Limited
Premium access

Shareholding and investment profile for Sameer Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Soni

Sameer Soni currently holds 1 directorship: Swarnkar Ayurveda Private Limited (Director, since 13 Sep 2022, revenue ₹2.7 Lakh (FY 2024)).

Sameer Soni was first appointed on 13 Sep 2022 as Director at Swarnkar Ayurveda Private Limited.

The current boards of Sameer Soni's companies include Mayank Soni (Swarnkar Ayurveda Private Limited), Priyanka Paliwal (Swarnkar Ayurveda Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available